Results 231 to 240 of about 8,810,905 (348)
Patents and technological development in the contexto of open science: perspectives on the influence of informational secrecy and proprietary research [PDF]
Janaina Laís Pacheco Lara Morandin +2 more
openalex
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
Enhancing translational research in metastatic cancer through an open science environment: the UPTIDER experience. [PDF]
Pabba A +24 more
europepmc +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira +14 more
wiley +1 more source
Beliefs about social dynamics and open science. [PDF]
Thomas A, Bourg C, Saxe R.
europepmc +1 more source
Data of Survey on National Contributions to EOSC and Open Science 2024
O'Neill, Gareth, Martziou, Stefania
openalex +1 more source
Support for open science is equally high in opt-in versus representative samples of scientists from a research-focused US university [PDF]
Ashley J Thomas +3 more
openalex +1 more source
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian +10 more
wiley +1 more source

